Memantine Market Poised for Growth Due to Advancements in Alzheimer's Disease Treatment Memantine is a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist primarily used for treating moderate to severe Alzheimer's disease. It functions by regulating glutamate activity and providing neuroprotection against toxicity. Memantine is approved as a treatment option either as a monotherapy or in combination with cholinesterase inhibitors for patients suffering from moderate to...
0 hisse senetleri
41 Views
0 önizleme